Literature DB >> 22327206

Anchoring the Panic Disorder Severity Scale.

Meghan E Keough1, Eliora Porter, M Alexandra Kredlow, John J Worthington, Elizabeth A Hoge, Mark H Pollack, M Katherine Shear, Naomi M Simon.   

Abstract

The Panic Disorder Severity Scale (PDSS) is a clinician-administered measure of panic disorder symptom severity widely used in clinical research. This investigation sought to provide clinically meaningful anchor points for the PDSS both in terms of clinical severity as measured by the Clinical Global Impression-Severity Scale (CGI-S) and to extend its clinical meaningfulness by examining its association with quality of life. A total of 63 individuals with a primary diagnosis of panic disorder were assessed on completion of a 6- or 8-week psychotherapy or pharmacotherapy trial for the treatment of panic disorder. As expected, the PDSS was correlated with both the CGI-S and quality of life. These results provide further support for the validity and clinical utility of the PDSS and provide simple anchors to help guide the potential use of the PDSS scale to measure treatment progress in clinical practice.

Entities:  

Mesh:

Year:  2012        PMID: 22327206      PMCID: PMC3600865          DOI: 10.1177/1073191112436668

Source DB:  PubMed          Journal:  Assessment        ISSN: 1073-1911


  8 in total

1.  Empirically supported psychological interventions: controversies and evidence.

Authors:  D L Chambless; T H Ollendick
Journal:  Annu Rev Psychol       Date:  2001       Impact factor: 24.137

Review 2.  Treatment of panic.

Authors:  Norman B Schmidt; Meghan E Keough
Journal:  Annu Rev Clin Psychol       Date:  2010       Impact factor: 18.561

3.  Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series.

Authors:  M W Otto; M H Pollack; S J Penava; B G Zucker
Journal:  Behav Res Ther       Date:  1999-08

4.  Reliability and validity of the Panic Disorder Severity Scale: replication and extension.

Authors:  M K Shear; P Rucci; J Williams; E Frank; V Grochocinski; J Vander Bilt; P Houck; T Wang
Journal:  J Psychiatr Res       Date:  2001 Sep-Oct       Impact factor: 4.791

5.  Multicenter collaborative panic disorder severity scale.

Authors:  M K Shear; T A Brown; D H Barlow; R Money; D E Sholomskas; S W Woods; J M Gorman; L A Papp
Journal:  Am J Psychiatry       Date:  1997-11       Impact factor: 18.112

6.  Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.

Authors:  J Endicott; J Nee; W Harrison; R Blumenthal
Journal:  Psychopharmacol Bull       Date:  1993

7.  The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Robert Jin; Ayelet Meron Ruscio; Katherine Shear; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2006-04

8.  Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.

Authors:  M H Pollack; M W Otto; J J Worthington; G G Manfro; R Wolkow
Journal:  Arch Gen Psychiatry       Date:  1998-11
  8 in total
  3 in total

1.  A network approach to modeling comorbid internalizing and alcohol use disorders.

Authors:  Justin J Anker; Miriam K Forbes; Zack W Almquist; Jeremiah S Menk; Paul Thuras; Amanda S Unruh; Matt G Kushner
Journal:  J Abnorm Psychol       Date:  2017-02-09

2.  Impact of Panic on Psychophysiological and Neural Reactivity to Unpredictable Threat in Depression and Anxiety.

Authors:  Lynne Lieberman; Stephanie M Gorka; Stewart A Shankman; K Luan Phan
Journal:  Clin Psychol Sci       Date:  2016-10-21

3.  An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder.

Authors:  Anish Shah; Joanne Northcutt
Journal:  Ann Gen Psychiatry       Date:  2018-05-11       Impact factor: 3.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.